GMMG Multiple Myeloma Registry

The goal of this observational study is to collect long-term clinical follow-up data on patients with multiple myeloma who participated in a therapy study of the German-Speaking Myeloma Multicenter Group (GMMG). Target variables of interest are: Overall survival, progression-free survival and follow-up time. The relevant registry data will be provided and evaluated together with the therapy study data for scientific research projects. This allows seamless documentation of patient data from the end of the trial to long-term follow-up.

NCT Number	NCT07111884
Lead Sponsor	Prof. Dr. Hartmut Goldschmidt Collaborators: Dietmar Hopp Stiftung, KKS Netzwerk, German Cancer Research Center
Conditions	Multiple Myeloma
Enrollment	999 participants
Start Date	2022-12-08
Primary Completion	2027-03 (estimated)
Study Completion	2027-03 (estimated)
Updated on ClinicalTrials.gov	2025-08-08